1. Genetic diversity of emerging Panton–Valentine leukocidine/arginine catabolic mobile element (ACME)-positive ST8 SCCmec-IVa meticillin-resistant Staphylococcus aureus (MRSA) strains and ACME-positive CC5 (ST5/ST764) MRSA strains in northern Japan
- Author
-
Noriko Urushibara, Masahiko Ito, Nobumichi Kobayashi, Kenji Kudo, Shigeo Morimoto, Osamu Kuwahara, Souvik Ghosh, and Mitsuyo Kawaguchiya
- Subjects
DNA, Bacterial ,Methicillin-Resistant Staphylococcus aureus ,Microbiology (medical) ,Genomic Islands ,Genotype ,Virulence Factors ,Bacterial Toxins ,Exotoxins ,Virulence ,Biology ,Arginine ,medicine.disease_cause ,Microbiology ,Genetic analysis ,Japan ,Leukocidins ,Arginine catabolic mobile element ,Genomic island ,Prevalence ,medicine ,SCCmec ,Haplotype ,Genetic Variation ,General Medicine ,Staphylococcal Infections ,Virology ,Interspersed Repetitive Sequences ,Staphylococcus aureus ,Coagulase - Abstract
Panton–Valentine leukocidine (PVL) is a distinctive virulence factor of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA), and arginine catabolic mobile element (ACME) is a staphylococcal genomic island that enhances fitness and the ability of bacterial cells to colonize on skin and mucous membranes. ACME is characteristically found in USA300, which is a predominant CA-MRSA clone [sequence type (ST) 8] in the USA and is spreading globally, and has also been detected in non-ST8 MRSA at low frequency. In Japan, spread of MRSA with PVL and/or ACME and their genetic traits have not yet been well characterized. In the present study, the prevalence and genetic diversity of PVL+/ACME+ MRSA were investigated for 422 MRSA clinical isolates collected from outpatients in northern Japan over a period of 1 year. All the isolates were genotyped for the staphylococcal cassette chromosome mec (SCCmec) and coagulase genes (coa), and screened for PVL and ACME genes. The PVL+/ACME+ isolates were studied further by genetic analysis, including single-nucleotide polymorphism (SNP) analysis based on PVL genes (lukS-PV-lukF-PV), ACME (arc and opp3 clusters) and the sarU promoter region. Among all the isolates examined, PVL genes and ACME were detected in eight (SCCmec-II, n = 1; SCCmec-IV, n = 6; SCCmec-V, n = 1) and 20 (SCCmec-II, n = 14; SCCmec-IV, n = 5; SCCmec-V, n = 1) isolates, respectively. Five isolates were found to have both PVL genes and ACME (type I), and were classified into ST8/spa-t008/agr-I/coa-IIIa, which is the same genetic traits as USA300. Fifteen PVL−/ACME+ isolates had type ΔII-ACME, belonging to either ST5 or ST764 [clonal complex (CC) 5], and spa-t001, -t002 or -t3557. All the ST8 PVL+/ACME-I+ MRSA had identical sequences of PVL genes (haplotype R) and ACME arc/opp3 clusters as those of USA300. In contrast, in the CC5 PVL−/ACME-ΔII+ MRSA, SNPs in the arc cluster were detected in 11 sites (four haplotypes), with some different profiles of virulence/resistance factors. These results indicated single clonality of ST8 PVL+/ACME-I+ MRSA and heterogeneity of CC5 PVL−/ACME-ΔII+ MRSA, and suggest their potential spread in northern Japan.
- Published
- 2013